Mangumpit, Max Kaiden .

HRN: 21-94-28  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2025
CEFTRIAXONE 1G (VIAL)
07/30/2025
08/06/2025
IV
450mg
Q8
TYPHOID FEVER
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: